← FDA DRUG APPROVALS

FDA ANDA · ANDA040899

HYDROXYZINE HYDROCHLORIDE

Sponsor: SUN PHARM INDS INC

APPLICATION
ANDA040899
TYPE
ANDA
ORIGINAL APPROVAL
2008-06-10
LATEST ACTION
2016-11-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDROXYZINE HYDROCHLORIDEDiscontinued
HYDROXYZINE HYDROCHLORIDE 25MG · TABLET · ORAL
HYDROXYZINE HYDROCHLORIDEDiscontinued
HYDROXYZINE HYDROCHLORIDE 50MG · TABLET · ORAL
HYDROXYZINE HYDROCHLORIDEDiscontinued
HYDROXYZINE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2016-11-08Labeling · Supplement 5 · standardAP
2016-03-30Labeling · Supplement 4 · standardAP
2014-06-03Labeling · Supplement 3 · standardAP
2008-06-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →